Carsten Thiel is a Berlin-born biochemistry guru. Thiel is an expert who spent his early days in Germany and started his journey of studying chemistry. After making a debut of the training at Malbrook, Thiel decided to travel to the United Kingdom to hone his chemistry skills. The Bristol University located in the Southwest part of the country became his destination. Thiel added a Bachelor of Science in organic chemistry from the institution to his portfolio.
However, Carsten Thiel chose biochemistry as the career of choice. Max Planck Institute became his home for the Biophysical Chemistry studies. Carsten Thiel specialized in the study of proteins and their influence on how healthy cells become cancerous. Carsten completed his studies and graduated with a Ph.D. in Molecular Biology.
As the Global Biotech Executive, the pharmaceutical expert believes in working in a scheduled manner. Besides having time with his family, Carsten updates himself with the news and the mails at hand. The next important task that he keeps in consideration is meeting with the company’s board for brief meetings.
According to Carsten, such meetings strengthen the bond between him and the rest of the board members. It’s one of the pillars of his success in the industry. The next important issue is communication with customers, investors, and other stakeholders. He admits that about 10% of his daily routine involves keeping in touch with the customers and doctors as well as other players in his company. Get Related Information Here.
Carsten Thiel finds time for his support staff in the day to ensure all is well. He is quick to mention these tasks are essential in every business or company. Many people overrule teamwork and end up failing miserably. Carsten attributes his success in biochemistry to early exposure from his family of medical.
An article with Medical Daily Times entitled “Carsten Thiel: Impactful Medicine”, talks about Thiel’s leadership, expertise, professional experience and contribution to the world of Biotechnology.
Carsten Thiel made a debut of his career at Hoffman La-Roche as the Products and communications manager. He also worked with Insadong Eastern Europe in the General Manager’s capacity before joining Abeona Therapeutics as the Chief Executive Officer. The Biopharmaceutical has served in many high profile companies that gave him the experience he needed to fit in the market.